Show simple item record

dc.contributor.authorGichangi, P.
dc.contributor.authorVuyst, H. De
dc.contributor.authorEstambale, Benson B.
dc.contributor.authorRogo, K.
dc.contributor.authorBwayo, J.
dc.contributor.authorTemmerman, M.
dc.date.accessioned2018-06-25T13:07:29Z
dc.date.available2018-06-25T13:07:29Z
dc.date.issued2002-01-22
dc.identifier.urihttps://obgyn.onlinelibrary.wiley.com/doi/full/10.1016/S0020-7292%2801%2900560-4#
dc.identifier.urihttps://doi.org/10.1016/S0020-7292(01)00560-4
dc.identifier.urihttp://ir.jooust.ac.ke:8080/xmlui/handle/123456789/1326
dc.descriptionhttps://doi.org/10.1016/S0020-7292(01)00560-4en_US
dc.description.abstractTo determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9‐year period when national HIV prevalence went from 5% to 5–10%, to 10–15%. Results:There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV‐negative women. Conclusions: A two‐ to three‐fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV‐positive women who presented with cervical cancer were significantly younger than HIV‐negative women.en_US
dc.language.isoenen_US
dc.publisherInternational Journal of Gynecology & Obstetricsen_US
dc.subjectHIVen_US
dc.subjectCervical canceren_US
dc.subjectKenyaen_US
dc.titleHIV and cervical cancer in Kenyaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record